Sage Journals: Discover world-class research

Abstract

Background. There are documented associations between elevated maternal corticotropin-releasing hormone (CRH) levels and adverse pregnancy outcomes. However, reports of these findings often lack sufficient detail and rationale regarding the bioassay methodology. This shortcoming can be problematic for researchers who do not possess in-depth laboratory sciences knowledge but who want to include bioassays in their investigations or to evaluate published reports. The quality and reliability of CRH measurement results can be significantly affected by variables encountered during sample collection, processing, storage, and bioassay. Thus, it is important to establish research laboratory protocols that are based on well-informed rationales and to carefully consider and control for relevant variables.

Approach. A synthesis of laboratory sciences literature regarding variables affecting CRH measurement in pregnancy is presented. Additionally, consultation with experienced researchers provided an in-depth understanding of CRH measurement. From these sources, a laboratory protocol for clinical research was developed.

Results. Multiple variables that are specific to the reliability of CRH measurement in pregnancy have been identified. These include sample collection methods, sample processing, sample integrity, sample storage, and the actual assay selected.

Conclusion. The reliability of CRH measurements can be significantly improved by identifying and controlling for variables encountered during sample collection, processing, storage, and bioassay. Adequate methodological details are difficult to glean solely from the published literature, thus consultation with well-informed researchers is necessary. A protocol for CRH bioassay in clinical research is proposed.

Keywords

corticotropin-releasing hormone pregnancy bioassay methodology

Get full access to this article

View all access options for this article.

References

Behan, D.P. , Khongsaly, O. , Liu, X.J. , Ling, N. , Goland, R. , Nasman, B. , et al. (1996). Measurement of corticotropin-releasing factor (CRF), CRF-binding protein (CRF-BP), and CRF/CRF-BP complex in human plasma by two-site enzyme-linked immunoabsorbant assay. The Journal of Clinical Endocrinology and Metabolism, 81, 2579-2586.

Challis, J.R.G. , Matthews, S.G. , Gibb, W. , & Lye, S.J. (2000). Endocrine and paracrine regulation of birth at term and preterm. Endocrine Reviews, , 21, 514-550.

Chrousos, G.P. (2000). The HPA axis and the stress response. Endocrine Research, 26, 513-514.

Ellis, J. , Livesey, J.H. , & Evans, M.J. (2003). Hormone stability in human whole blood. Clinical Biochemistry, 36, 109-112.

Emanuel, R.L. , Robinson, B.G. , Seely, E.W. , Graves, S.W. , Kohane, I. , Saltzman, D. , et al. (1994). Corticotrophin releasing hormone levels in human plasma and amniotic fluid during gestation. Clinical Endocrinology (Oxford), 40, 257-262.

Erickson, K. , Thorsen, P. , Chrousos, G. , Grigoriadis, D.E. , Khongsaly, O. , McGregor, J. , et al. (2001). Preterm birth: Associated neuroendocrine, medical, and behavioral risk factors. The Journal of Clinical Endocrinology and Metabolism, 86, 2544-2552.

Evans, M.J. , Livesey, J.H. , Ellis, M.J. , & Yandle, T.G. (2001). Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones. Clinical Biochemistry , 34, 107-112.

Guder, W. , Narayanan, S. , Wisser, H. , & Zawta, B. (2003). Samples: From the patient to the laboratory. The impact of preanalytical variables on the quality of laboratory samples (3rd ed.). Weinheim, Germany: Wiley-VCH Verlog GmbH & Co.

Hobel, C.J. , Arora, C.P. , & Korst, L.M. (1999). Corticotrophin-releasing hormone and CRH-binding protein. Differences between patients at risk for preterm birth and hypertension . Annals of the New York Academy of Sciences, 897, 54-65.

10.

Hobel, C.J. , & Culhane, J. (2003). Role of psychosocial and nutritional stress on poor pregnancy outcome. Journal of Nutrition, 133(5 Suppl 2), 1709S-1717S.

11.

Hobel, C.J. , Dunkel-Schetter, C. , Roesch, S.C. , Castro, L.C. , & Arora, C.P. (1999). Maternal plasma corticotropin-releasing hormone associated with stress at 20 weeks' gestation in pregnancies ending in preterm delivery. American Journal of Obstetrics and Gynecology, 180(1 Pt 3), S257-S263.

12.

Holzman, C. , Jetton, J. , Siler-Khodr, T. , Fisher, R. , & Rip, T. (2001). Second trimester corticotropin-releasing hormone levels in relation to preterm delivery and ethnicity. Obstetrics and Gynecology, 97(5 Pt 1), 657-663.

13.

Linton, E.A. , Perkins, A.V. , Hagan, P. , Poole, S. , Bristow, A.F. , Tilders, F. , et al. (1995). Corticotrophin-releasing hormone (CRH)-binding protein interference with CRH antibody binding: Implications for direct CRH immunoassay. Journal of Endocrinology, 146, 45-53.

14.

Lockwood, C.J. , & Kuczynski, E. (2001). Risk stratification and pathological mechanisms in preterm delivery. Paediatric and Perinatal Epidemiology , 15(Suppl 2), 78-89.

15.

Lockwood, C.J. , Radunovic, N. , Nastic, D. , Petkovic, S. , Aigner, S. , & Berkowitz, G.S. (1996). Corticotropin-releasing hormone and related pituitary-adrenal axis hormones in fetal and maternal blood during the second half of pregnancy. Journal of Perinatal Medicine, 24, 243-251.

16.

Mancuso, R.A. , Schetter, C.D. , Rini, C.M. , Roesch, S.C. , & Hobel, C.J. (2004). Maternal prenatal anxiety and corticotropin-releasing hormone associated with timing of delivery. Psychosomatic Medicine, , 66, 762-769.

17.

McGrath, S. , McLean, M. , Smith, D. , Bisits, A. , Giles, W. , & Smith, R. (2002). Maternal plasma corticotropin-releasing hormone trajectories vary depending on the cause of preterm delivery. American Journal of Obstetrics and Gynecology, 186, 257-260.

18.

McLean, M. , & Smith, R. (2001). Corticotrophin-releasing hormone and human parturition . Reproduction, 121, 493-501.

19.

Norwitz, E.R. , Robinson, J.N. , & Challis, J.R. (1999). The control of labor. New England Journal of Medicine, 341, 660-666.

20.

Peninsula (2006). General protocol for peptide radioimmunoassay. San Carlos, CA: Peninsula Laboratories, Inc.

21.

Petraglia, F. , Genazzani, A.D. , Aguzzoli, L. , Gallinelli, A. , de Vita, D. , Caruso, A. , et al. (1994). Pulsatile fluctuations of plasma-gonadotropin-releasing hormone and corticotropin-releasing factor levels in healthy pregnant women . Acta Obstetricia et Gynecologica Scandinavica, 73, 284-289.

22.

Ruiz, R.J. , Fullerton, J. , Brown, C.E. , & Dudley, D.J. (2002). Predicting risk of preterm birth: The roles of stress, clinical risk factors, and corticotropin-releasing hormone. Biological Research for Nursing, 4, 54-64.

23.

Sandman, C.A. , Glynn, L. , Schetter, C.D. , Wadhwa, P. , Garite, T. , Chicz-DeMet, A. , et al. (2006). Elevated maternal cortisol early in pregnancy predicts third trimester levels of placental corticotropin releasing hormone (CRH): Priming the placental clock. Peptides, 27, 1457-1463.

24.

Sibai, B. , Meis, P.J. , Klebanoff, M. , Dombrowski, M.P. , Weiner, S.J. , Moawad, A.H. , et al. (2005). Plasma CRH measurement at 16 to 20 weeks' gestation does not predict preterm delivery in women at high-risk for preterm delivery. American Journal of Obstetrics and Gynecology, 193(3 Pt 2), 1181-1186.

25.

Siler-Khodr, T.M. , Forthman, G. , Khodr, C. , Matyszczyk, S. , Khodr, Z. , & Khodr, G. (2003). Maternal serum corticotropin-releasing hormone at midgestation in Hispanic and White women. Obstetrics and Gynecology, 101, 557-564.

26.

Smith, R. , Mesiano, S. , & McGrath, S. (2002). Hormone trajectories leading to human birth. Regulatory Peptides, 108, 159-164.

27.

Sorem, K.A. , Smikle, C.B. , Spencer, D.K. , Yoder, B.A. , Graveson, M.A. , & Siler-Khodr, T.M. (1996). Circulating maternal corticotropin-releasing hormone and gonadotropin-releasing hormone in normal and abnormal pregnancies . American Journal of Obstetrics and Gynecology, 175(4 Pt 1), 912-916.

28.

Strong, E.F. , Kleinman, K.P. , Gillman, M.W. , Clark, I. , Emanuel, R.L. , Majzoub, J.A. , et al. (2006). Measuring corticotropin-releasing hormone in pregnant women-comparing blood collection protocols for epidemiological studies. Paediatric and Perinatal Epidemiology, 20, 67-71.

29.

Torricelli, M. , Ignacchiti, E. , Giovannelli, A. , Merola, A. , Scarpetti, E. , Calonaci, G. , et al. (2006). Maternal plasma corticotrophin-releasing factor and urocortin levels in post-term pregnancies. European Journal of Endocrinology, 154, 281-285.

30.

Wadhwa, P.D. , Garite, T.J. , Porto, M. , Glynn, L. , Chicz-DeMet, A. , Dunkel-Schetter, C. , et al. (2004). Placental corticotropin-releasing hormone (CRH), spontaneous preterm birth, and fetal growth restriction: A prospective investigation. American Journal of Obstetrics and Gynecology , 191, 1063-1069.

Bioassay Research Methodology: Measuring CRH in Pregnancy

Abstract

Keywords

Get full access to this article

References